The 12 closest competitors and alternatives to Violet Therapeutics, Inc. — ranked by similarity to what Violet Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Violet Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Violet Therapeutics, Inc. is a company headquartered in United States. Its most recent funding round raised $7.4M in April 2023. Xcout tracks 10 named people at Violet Therapeutics, Inc., including Darby Schmidt (Chief Science Officer).
4 more named people on record for Violet Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7.4M | — | |
| Seed | $10.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Violet Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
Biotechnology
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Close match by what they do
DeepBiome Therapeutics, Inc. is a venture-backed startup company headquartered in Cambridge, Massachusetts, focused on therapeutics.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Biotech
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Biotechnology
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Biotechnology
CHARM Therapeutics Inc. is a biopharmaceutical company utilizing proprietary technology platforms for drug discovery and therapeutic pipeline development.
Close match by what they do
VBI Vaccines Inc. is a biopharmaceutical company driven by immunology to develop novel technologies that expand vaccine protection and treatment of diseases, located in Cambridge, Massachusetts.
Close match by what they do
Vigeo Therapeutics, Inc. is a biotechnology holding company founded in 2011 and based in Massachusetts. The firm develops drug pipelines and operates within the life sciences sector.
Biotech
Vivatides Therapeutics Inc. is a privately held biotechnology company founded in 2025 and headquartered in Woburn, Massachusetts. The company maintains a small team focused on therapeutics research and development.
Biotechnology
Valink Therapeutics Inc. is a biotechnology research company headquartered in Cambridge, Massachusetts, with a research and development subsidiary located in London, United Kingdom.
Therapeutics
Founded in 2017 and headquartered in Cambridge, Massachusetts, Comet Therapeutics, Inc. specializes in creating therapeutics targeting specific biological pathways.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Violet Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →